ALICO, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ALICO, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	144	130	81.3	122	92.5	109	91.9	39.8	46.6	44.1
Cost of revenue	109	121	55.7	61.9	74.6	84.7	107
Gross profit	35.1	8.93	25.6	60.4	17.9	23.9	-14.8	6.45	-56.4	-192
General and administrative	13.2	15	15.1	15.1	11	9.45	10.1	10.6	11.1	11.7
Operating income	21.8	-6.09	10.5	45.2	6.92	14.4	-24.8	-4.2	-67.5	-204
Interest expense	9.89	9.14	8.56	7.18	5.98	3.99	3.32	4.91	3.54	4.85
Other non-operating income	-9.37	-7.25	2.66	5.02	24.5	31.9	37.8	6.66	78.4	18
Pre-tax income	12.5	-13.3	13.2	50.2	31.4	46.4	13	2.46	11	-186
Income tax	5.52	-3.85	0.39	12.8	7.66	11.6	1.07	0.8	4.6	-38.4
Net income to minority interests	-0.03	-0.05	-0.25	-0.38	0.05	-0.04	-0.57	-0.18	-0.62	-0.17
Net income	6.99	-9.45	13.1	37.8	23.7	34.9	12.5	1.84	6.97	-147
EBITDA	37.2	9.13	24.3	58.8	21.2	29.6	-9.62	11.3	-52.4	-27.3
EPS, basic	0.84	-1.14	1.59	5.06	3.16	4.64	1.65	0.24	0.91	-19.29
EPS, diluted	0.84	-1.14	1.57	5.05	3.16	4.64	1.65	0.24	0.91	-19.29
Shares, basic (weighted)	8.3	8.3	8.23	7.47	7.48	7.52	7.56	7.6	7.62	7.64
Shares, diluted (weighted)	8.31	8.3	8.3	7.49	7.5	7.52	7.57	7.6	7.62	7.64
Dividend per share	0.24	0.24	0.24	0.24	0.36	1.36	2.00	0.20	0.20	0.20

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	6.63	3.4	25.3	18.6	3.16	0.89	0.87	1.06	3.15	38.1
Receivables	4.74	4.29	2.54	0.71	4.35	6.11	0.32	0.71	0.77	1.01
Inventory	58.5	36.2	41	40.1	40.9	43.4	27.7	52.5	30.1	4.22
Other current assets	2.26	1.62	0.83	1.05	1.39	1.15	1.42	1.72	1.56	2.04
Total current assets	71.9	66.5	71.1	62	51.9	54.9	31.6	58.8	40.6	54.9
Property, plant and equipment	379	349	340	350	350	373	372	362	353	142
Lease right-of-use assets					0.77	0.29	0.76	0.52	0.29	0.15
Goodwill	2.25	2.25	2.25	2.25	2.25	2.25	2.25	2.25	2.25	2.25
Other non-current assets	1.69	0.85	2.71	2.31	3.21	2.83	2.91	2.82	2.87	1.54
Total assets	455	419	423	417	424	433	409	428	399	202
Accounts payable	5.98	3.19	3.76	4.16	3.53	7.27	3.37	6.31	3.36	0.4
Accrued liabilities	6.92	6.78	8.88	7.77	7.1	9.87	9.06	5.36	5.37	4.56
Short-term debt	4.49	4.55	5.28	5.34	9.15	4.29	3.04	2.57	1.41	0.25
Total current liabilities	18.7	16	21.5	29	21.2	22.3	16.5	15.1	10.7	5.74
Long-term debt	193	182	169	158			103	101	82.3	82.8
Lease liabilities					0.36	0.04	0.39	0.31	0.17	0.01
Other non-current liabilities			0.02	0.17	0.37	0.31	0.44	0.37	0.19	0.04
Total liabilities	277	254	246	218	202	183	160	178	142	93.5
Total debt	197	186	174	163	9.15	4.29	106	104	83.7	83
Paid-in capital	18.2	18.7	20.1	19.8	19.7	20	19.8	20	20.2	20.4
Retained earnings	152	140	151	198	219	246	243	244	249	100
Treasury stock	-4.59	-6.5	-7.54	-31.9	-30.8	-29.9	-27.9	-27.3	-26.7	-26.2
Shareholders' equity	173	161	172	194	216	245	244	245	251	103
Minority interests	4.77	4.73	5.48	5.1	5.44	5.4	5.12	5.39	5.14	4.96
Total equity	178	165	178	202	224	250	249	250	256	108
Total liabilities and equity	455	419	423	417	424	433	409	428	399	202
Shares outstanding	8.32	8.24	8.2	7.48	7.49	7.56	7.59	7.61	7.63	7.65

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	6.96	-9.5	12.8	37.5	23.7	34.8	11.9	1.66	6.36	-148
Depreciation and amortization	15.4	15.2	13.8	13.6	14.3	15.1	15.2	15.5	15	177
Stock-based compensation	0.92	1.65	2.61	0.82	1.31	1.23	1.24	0.94	0.72	0.74
Deferred income tax	5.28	-3.95	-1.96	3.27	7.6	2.25	-3.88	0.82	4.46	-38.4
Change in receivables	-1.71	0.14	1.72	1.53	-3.63	-1.76	5.78	-0.39	-0.06	-0.24
Change in inventory	-0.2	3.72	-6.55	0.08	-0.71	-2.52	-5.88	-26.4	-26.3	16
Change in payables	3.72	-2.9	2.99	-1.11	-1.53	3.43	-5.11	2.42	-3.37	-3.31
Cash from operations	30.4	27.5	18.6	48.8	1.05	16.5	6.52	-6.25	-30.5	20.1
Capital expenditures	-14.3	-13.4	-16.4	-18.1	-18.8	-22.3	-20.7	-16.7	-17.9	-5.5
Acquisitions	0	0
Cash from investing	-13	-9.34	22.9	-4.96	9.49	-3.27	22.5	-4.12	68.2	24.1
Debt issued	2.5	0	0
Debt repaid	0	0
Stock issued						0	0.47	0
Share buybacks	-3.14	-3.06	-2.22	-25.6	-0.24
Dividends paid	-1.99	-1.99	-1.97	-1.83	-2.47	-7.14	-15.1	-4.93	-1.52	-1.53
Cash from financing	-16.2	-21.4	-12.6	-52.3	-14.7	-32	-29	13.2	-38	-8.78
Net change in cash	1.15	-3.23	28.9	-8.42	-4.15	-18.8	-0.02	2.83	-0.29	35.5
Free cash flow	16.1	14.1	2.23	30.8	-17.7	-5.75	-14.2	-22.9	-48.4	14.6
Interest paid	7.53	7.24	6.72	6.94	5.83	3.94	3.19	4.43	3.85	3.92
Income taxes paid	-0.88	-0.91	0.03	6.29	6.4	11.8	3.43	0	0.89	-1.62

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $39.07 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	-72.1%	Gross profit / revenue.
Operating margin	-170.6%	Operating income / revenue.
EBITDA margin	-61.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-7.4%	Pre-tax income / revenue.
Net margin	9.0%	Net income / revenue.
FCF margin	-20.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-2.2%	Cash from operations / revenue.
Return on equity (ROE)	1.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.8%	Net income / average total assets.
Return on invested capital (ROIC)	-17.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	3.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	18.6%	Capital expenditures / revenue.
D&A / revenue	109.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-21.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-13.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-2,213.0%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-2,220.0%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	45.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	80.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-53.6%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	-11.1%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-59.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-25.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-13.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-49.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-21.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-13.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	7.96x	Current assets / current liabilities.
Quick ratio	7.73x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	7.64x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.79x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	41.7%	Total debt / total assets.
Liabilities / assets	47.2%	Total liabilities / total assets.
Net debt	$27.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-6.12x	Operating income / interest expense.
Working capital	$50.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	1.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$102.6M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.09x	Revenue / average total assets.
Fixed asset turnover	0.13x	Revenue / average property, plant and equipment.
Receivables turnover	28.9x	Revenue / average receivables.
Days sales outstanding	13 days	365 x average receivables / revenue.
FCF conversion	-231.8%	Free cash flow / net income, when net income is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.21	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$2.30	Revenue / diluted weighted shares.
FCF per share	-$0.48	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$0.05	Cash from operations / diluted weighted shares.
Book value per share	$14.13	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$13.83	Tangible book value / shares outstanding.
Cash per share	$7.49	(Cash + short-term investments) / shares outstanding.
Payout ratio	99.2%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$289.8M	Share price x shares outstanding.
Enterprise value	$317.2M	Market cap + total debt - cash - short-term investments.
P/E	189x	Market cap / net income. Only when net income is positive.
P/S	17.0x	Market cap / revenue.
P/B	2.76x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.83x	Market cap / tangible book value, when positive.
EV/Sales	18.6x	Enterprise value / revenue.
FCF yield	-1.2%	Free cash flow / market cap.
Earnings yield	0.5%	Net income / market cap (the inverse of P/E).
Dividend yield	0.5%	Dividends paid over the period / market cap.
Shareholder yield	0.5%	(Dividends paid + share buybacks) / market cap.

What was ALICO, INC.'s revenue in fiscal 2025?

ALICO, INC. reported revenue of $44.1M for fiscal 2025, 5.5% lower than the year before.

Was ALICO, INC. profitable in fiscal 2025?

No. It reported a net loss of $147.3M.

How much free cash flow did ALICO, INC. generate in fiscal 2025?

Cash from operations of $20.1M minus capital expenditures of $5.5M left free cash flow of $14.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ALICO, INC.